{"slug":"semaglutide-insomnia","verification":{"valid":true,"entries":2,"head":"c0be89bb1c246362da9d9b86677feeea87b52a603fe8a5f0e00c6733622956bb"},"energy":{"passes":2,"tokens_in":15370,"tokens_out":3181,"tokens_total":18551,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"c0be89bb1c246362da9d9b86677feeea87b52a603fe8a5f0e00c6733622956bb"},"provenance":[{"ts":"2026-06-30T00:25:24.970Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semaglutide for Insomnia\nSlug: semaglutide-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semaglutide\",\"name\":\"Semaglutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semaglutide\",\"name\":\"Semaglutide\",\"section_title\":\"Why Semaglutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\",\"**What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\",\"**Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\\n2. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\\n3. **Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compo","response":"{\n  \"slug\": \"semaglutide-insomnia\",\n  \"title\": \"Semaglutide for Insomnia: Evidence on Metabolic Pathways and Sleep\",\n  \"body\": \"## What's breaking down\\n\\nInsomnia often involves disrupted sleep regulation tied to metabolic stress. Excess body weight increases mechanical load on the respiratory system during sleep. This can lead to breathing interruptions that fragment rest. Metabolic factors also influence inflammation and hormone balance that affect sleep continuity. When these layers persist, repair processes for consistent sleep fall behind degeneration from ongoing stress. Semaglutide targets one such layer through studied effects on body weight and related metabolic load.\\n\\n## Why Semaglutide might help you\\n\\n1. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\\n2. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\\n3. **Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nIf body weight contributes to nighttime breathing strain that fragments sleep, the weight reduction pathway may ease that strain. Reduced load on tissues and systems could support more stable sleep patterns over time. This framing stays on repair of the underlying metabolic contributor rather than direct symptom suppression.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Semaglutide** → metabolic load / body weight\\n\\n## What the evidence actually shows\\n\\nHuman trial data show insomnia rates with semaglutide match placebo at 2.4 percent (human tier). No dedicated human trials test semaglutide directly for insomnia treatment (human tier). Observational data link GLP-1 agonists including semaglutide to lower obs","tokens_in":15370,"tokens_out":3181,"cost":0,"prev":"genesis","hash":"47e4336bb013955085d2b40890ea593965a5e5c903d87d99ac344b81cf0f3fa6"},{"ts":"2026-07-17T02:41:46.553Z","model":"owner","action":"voxel_divide","prompt":"","input":"semaglutide-insomnia","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"47e4336bb013955085d2b40890ea593965a5e5c903d87d99ac344b81cf0f3fa6","hash":"c0be89bb1c246362da9d9b86677feeea87b52a603fe8a5f0e00c6733622956bb"}]}